A L Barry - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A L Barry

Showing results (321-330 of 420) with videos related to

Pageof 42

Sort By:

Journal of Clinical Microbiology|May 1, 1982

Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazoneC Thornsberry, A L Barry, R N Jones, et al.

Journal of Clinical Microbiology|October 1, 1991

Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacinP C Fuchs, A L Barry, C Baker, et al.

American Journal of Clinical Pathology|November 1, 1986

The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactamR N Jones, A L Barry, C Thornsberry, et al.

Antimicrobial Agents and Chemotherapy|May 23, 2002

Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methodsA L Barry, M A Pfaller, R P Rennie, et al.

Antimicrobial Agents and Chemotherapy|January 1, 1995

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study GroupJ H Rex, M A Pfaller, A L Barry, et al.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1990

Prevalence of fluoroquinolone-resistant bacterial isolates in four medical centers during the first quarter of 1990A L Barry, P C Fuchs, M A Pfaller, et al.

Journal of Clinical Microbiology|August 1, 1992

Proposed interpretive criteria and quality control parameters for testing susceptibility of Neisseria gonorrhoeae to beta-lactam-clavulanate combinationsP C Fuchs, A L Barry, C N Baker, et al.

Journal of Clinical Microbiology|August 1, 1992

Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strainJ H Jorgensen, A L Barry, G V Doern, et al.

European Journal of Clinical Microbiology|June 1, 1984

In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centersA L Barry, L W Ayers, T L Gavan, et al.

The Journal of Antimicrobial Chemotherapy|April 1, 1986

Activity of temocillin and ticarcillin against consecutively isolated Enterobacteriaceae in four medical centresA L Barry, R N Jones, L W Ayers, et al.

Pageof 42

Search research articles

Showing results (321-330 of 420) with videos related to

Sort By:

Pageof 42

Journal of Clinical Microbiology|May 1, 1982

Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazoneC Thornsberry, A L Barry, R N Jones, et al.

Journal of Clinical Microbiology|October 1, 1991

Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacinP C Fuchs, A L Barry, C Baker, et al.

American Journal of Clinical Pathology|November 1, 1986

The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactamR N Jones, A L Barry, C Thornsberry, et al.

Antimicrobial Agents and Chemotherapy|May 23, 2002

Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methodsA L Barry, M A Pfaller, R P Rennie, et al.

Antimicrobial Agents and Chemotherapy|January 1, 1995

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1990

Prevalence of fluoroquinolone-resistant bacterial isolates in four medical centers during the first quarter of 1990A L Barry, P C Fuchs, M A Pfaller, et al.

Journal of Clinical Microbiology|August 1, 1992

Proposed interpretive criteria and quality control parameters for testing susceptibility of Neisseria gonorrhoeae to beta-lactam-clavulanate combinationsP C Fuchs, A L Barry, C N Baker, et al.

Journal of Clinical Microbiology|August 1, 1992

European Journal of Clinical Microbiology|June 1, 1984

In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centersA L Barry, L W Ayers, T L Gavan, et al.

The Journal of Antimicrobial Chemotherapy|April 1, 1986

Activity of temocillin and ticarcillin against consecutively isolated Enterobacteriaceae in four medical centresA L Barry, R N Jones, L W Ayers, et al.

Pageof 42